生命科学资讯

United Therapeutics to take pulmonary hypertension drug to FDA for approval

Aardvark's stock plummets on study pause; BioNTech heads to Phase 3 with DualityBio ADC

Roche gets third pivotal win with MS drug, but liver signal could be a problem

FDA lifts hold on second Intellia Phase 3 gene editing trial

Candid to go public via reverse merger with Rallybio

Bavarian Nordic CEO Paul Chaplin exits, months after failed $3B takeover

UniQure says FDA prefers randomized trial for Huntington's treatment

Novartis' Rhapsido shows promise in Phase 2 food allergy data

Merck looks to expand Welireg label following combo readouts with Keytruda, Lenvima

GLP-1 news galore; Top 100 venture investors; Doug Ingram to step down; and more

Ascendis wins FDA approval for achondroplasia drug, waits on EU action

Novartis, Takeda to enter next Medicare drug price negotiations

US International Trade Commission to take a closer look at Chinese biotech

Merck cuts more than 150 jobs at new Gardasil vaccine plant in North Carolina

CHMP recommends Moderna's flu-Covid shot and Novartis pill for hives

Generate:Biomedicines raises $400M IPO, CEO talks about AI's future in drug design

Ginkgo divests biosecurity arm; J&J's early prostate cancer data

Padcev-Keytruda combo delivers more positive data in bladder cancer

Novartis closes Avidity deal as rare heart disease spinout launches

Investors are pumping money into AI tools for health insurers